Literature DB >> 18057772

Irreversible imatinib-induced pneumonitis following long-term imatinib administration.

Nobuhiko Seki1, Akemi Ito, Kennichi Watanabe, Reishi Shibakuki, Takashi Seto, Kazutsugu Uematsu, Tetsuya Mine, Kenji Eguchi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 18057772     DOI： 10.2169/internalmedicine.46.0542

Source DB:  PubMed          Journal:  Intern Med        ISSN： 0918-2918            Impact factor:   1.271


× No keyword cloud information.
  3 in total

1.  Successful rechallenge with imatinib in a patient with chronic myeloid leukemia who previously experienced imatinib mesylate induced pneumonitis.

Authors:  Seong Woo Go; Boo Kyeong Kim; Sung Hak Lee; Tae-Jung Kim; Joo Yeon Huh; Jong Min Lee; Jick Hwan Hah; Dong Whi Kim; Min Jung Cho; Tae Wan Kim; Ji Young Kang
Journal:  Tuberc Respir Dis (Seoul)       Date:  2013-12-24

2.  Imatinib-induced irreversible interstitial lung disease: A case report.

Authors:  Ping Zhang; Jingfeng Huang; Fangfang Jin; Jiaohai Pan; Guifang Ouyang
Journal:  Medicine (Baltimore)       Date:  2019-02       Impact factor: 1.889

3.  Tuberculous and non-tuberculous granulomatous lymphadenitis in patients receiving imatinib mesylate (glivec) for metastatic gastrointestinal stromal tumor.

Authors:  Abbas Agaimy; Valeska Brueckl; Daniela Schmidt; Stephanie Krieg; Evelyn Ullrich; Norbert Meidenbauer
Journal:  Case Rep Oncol       Date:  2013-03-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.